Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25136917 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Crawford Currie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hofseth BioCare, Keiser Wilhelms Gate 24, 6003 Alesund, Norway. Hauptthemen laut MEDLINE: Fish Oils, COVID-19, Interferons, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hofseth BioCare.
Abstract (Originalsprache)
Cytokines, chemokines, and interferons are released in response to viral infection with the ultimate aim of viral clearance. However, in SARS-CoV-2 infection, there is an imbalanced immune response, with raised cytokine levels but only a limited interferon response with inefficient viral clearance. Furthermore, the inflammatory response can be exaggerated, which risks both acute and chronic sequelae. Several observational studies have suggested a reduced risk of progression to severe COVID-19 in subjects with a higher omega-3 index. However, randomized studies of omega-3 supplementation have failed to replicate this benefit. Omega-3 fats provide important anti-inflammatory effects; however, fatty fish contains many other fatty acids that provide health benefits distinct from omega-3. Therefore, the immune health benefit of whole salmon oil (SO) was assessed in adults with mild to moderate COVID-19. Eleven subjects were randomized to best supportive care (BSC) with or without a full spectrum, enzymatically liberated SO, dosed at 4g daily, for twenty-eight days. Nasal swabs were taken to measure the change in gene expression of markers of immune response and showed that the SO provided both broad inflammation-resolving effects and improved interferon response. The results also suggest improved lung barrier function and enhanced immune memory, although the clinical relevance needs to be assessed in longer-duration studies. In conclusion, the salmon oil was well tolerated and provided broad inflammation-resolving effects, indicating a potential to enhance immune health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hofseth BioCare, Keiser Wilhelms Gate 24, 6003 Alesund, Norway.
- Department of Research and Innovation, More og Romsdal Hospital Trust, 6026 Ålesund, Norway.
- Department of Registration, Cancer Registry of Norway, 0379 Oslo, Norway.
ORCID-Profile: Crawford Currie, Bomi Framroze
Förderung
- Hofseth BioCare
Zitieren
APA
Currie, C., Myklebust, T. Å., Bjerknes, C., & Framroze, B. (2024). Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25136917
Vancouver
Currie C, Myklebust TÅ, Bjerknes C, Framroze B. Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25136917
BibTeX
@article{Currie2024,
author = {Currie, Crawford and Myklebust, Tor Åge and Bjerknes, Christian and Framroze, Bomi},
title = {Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25136917}
}
EUVIMED